Aprogen Biologics Inc. (KRX:003060)

Aprogen Biologics Revenue

Aprogen Biologics had revenue of 16.85B KRW in the quarter ending March 31, 2025, with 7.96% growth. This brings the company's revenue in the last twelve months to 68.62B, down -19.76% year-over-year. In the year 2024, Aprogen Biologics had annual revenue of 67.38B, down -22.88%.

• Revenue (ttm): 68.62B
• Revenue Growth: -19.76%
• P/S Ratio: 1.90
• Revenue / Employee: 182.02M
• Employees: 377
• Market Cap: 130.20B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	67.38B	-19.99B	-22.88%
Dec 31, 2023	87.36B	22.17B	34.01%
Dec 31, 2022	65.19B	8.71B	15.42%
Dec 31, 2021	56.48B	3.16B	5.93%
Dec 31, 2020	53.32B	2.42B	4.75%